Article
FDA’s One-Day Inspectional Assessments Pilot: A Risk-Based Shift In Oversight — What Regulated Entities Need To Know And How To Comply
On May 6, 2026, the U.S. Food & Drug Administration (FDA) announced the launch of a pilot program for one-day inspectional assessments — a new, streamlined screening tool designed to make the agency’s inspectional resources more targeted and efficient.
Foley & Lardner